Revenue

Plus Therapeutics' REYOBIQ gains a crucial CPT code, a vital step in bringing this targeted radiotherapy to patients with aggressive brain cancers.

Landmark rulings in Canada & the U.S. sanction regulators for misconduct in the MyForexFunds case, raising serious questions about accountability.

A novel nasal spray for progressive MS shows it can calm brain inflammation and boost neuroprotection, offering new hope for a difficult-to-treat disease.

U.S. Energy Corp. unveils an ambitious plan to merge helium, oil, and carbon capture, but can this small-cap company deliver on its big promises?

Avista posts strong utility earnings but faces hurdles from investment losses and a key customer departure, unveiling a multi-billion dollar grid plan.

Rise Wellness launches its new 30g carbonated protein drink at Costco, betting on fizz and function to capture a rapidly growing, competitive market.

With its stock lagging, TScan Therapeutics will use a key conference to highlight upcoming clinical trial data and convince investors of its pipeline's value.

The fashion giant's revenue grew 11% in 2025, but net income fell sharply due to acquisition costs, tariffs, and a murky outlook for 2026.

With an $11.75M boost, a new device promises blood results in minutes, not hours, signaling a major pharma player's strategic pivot into diagnostics.

With $400M in 2025 sales, Immunocore now leverages its KIMMTRAK success to fund a high-stakes pivot into broader cancers, HIV, and autoimmune disease.

Ex-Google and Salesforce leader David Keene joins Agentive as Co-Founder, betting on agentic AI to solve the costly complexity of modern B2B sales tools.

With sales rising and key FDA milestones met, Australian biotech Immuron resets its strategy, seeking partners to fund its promising infectious disease pipeline.

The cold storage giant saw strong cash flow growth in 2025 despite a net loss, but its conservative 2026 forecast signals persistent industry headwinds.

A landmark partnership aims to bring precision cancer therapy, or Theranostics, to millions in underserved nations, backed by a major WHO resolution.

A new partnership between Amilia and CampDoc promises to eliminate data headaches for directors and enhance child safety through integrated, secure technology.

The secure identity firm beat Wall Street estimates with accelerating revenue and record cash flow, signaling major growth and increased shareholder returns.

After record-breaking devastation, a new national program is training a generation of fire specialists to use controlled burns to prevent megafires.

A new partnership between Salience Labs and Tower Semiconductor aims to mass-produce optical switches, a critical technology for faster, greener AI data centers.

Arya.ai's Cred AI moves beyond simple automation, offering contextual intelligence to help lenders understand the 'why' behind financial data.

Industry leaders ILMC and Pollstar are launching a major conference in Abu Dhabi, cementing the region's status as a burgeoning global entertainment hub.